Chemical Structure : EG00229
CAS No.: 1210945-69-9
Catalog No.: PC-42701Not For Human Use, Lab Use Only.
EG00229 is the first small molecule ligand for the VEGF-A receptor neuropilin 1 (NRP1), selectively inhibits radiolabeled 125I-VEGF-A binding to PAE/NRP1 with IC50 of 8 uM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $128 | In stock | |
10 mg | $198 | In stock | |
25 mg | $348 | In stock | |
50 mg | $558 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
EG00229 is the first small molecule ligand for the VEGF-A receptor neuropilin 1 (NRP1), selectively inhibits radiolabeled 125I-VEGF-A binding to PAE/NRP1 with IC50 of 8 uM.
EG00229 inhibits bt-VEGF-A binding to purified NRP1 b1 domain in a cell-free assay with an IC50 of 3 uM.
EG00229 shows no effect on VEGFA binding to VEGFR-1 and VEGFR-2.
EG00229 attenuates VEGFR2 phosphorylation and inhibits migration in endothelial cells.
M.Wt | 611.595 | |
Formula | C19H20F3N7O7S3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 41.4 mg/mL |
|
Chemical Name/SMILES |
L-Arginine, N2-[[3-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-2-thienyl]carbonyl]-, 2,2,2-trifluoroacetate (1:1) |
1. Jarvis A, et al. J Med Chem. 2010 Mar 11;53(5):2215-26.
2. Nissen JC, et al. J Neurochem. 2013 Nov;127(3):394-402.
3. Miyauchi JT, et al. Oncotarget. 2016 Mar 1;7(9):9801-14.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright